To include your compound in the COVID-19 Resource Center, submit it here.

Humira adalimumab regulatory update

ABT submitted an sBLA to the FDA and a Type

Read the full 106 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE